Clinical and experimental aspects of tirbanibulin treatments
Archives of Dermatological Research · 2025
DOI: 10.1007/s00403-025-04119-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archives of Dermatological Research, 2025. Verfasst von Annabel Shen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The University of Texas McGovern Medical School, 6431 Fannin St, Houston, TX, 77070, USA. Hauptthemen laut MEDLINE: Skin Neoplasms, Keratosis, Actinic, Basal Cell Carcinoma, Carcinoma, Squamous Cell. Die Arbeit nennt 55 Literaturangaben.
Abstract (Originalsprache)
Tirbanibulin is a topical medication approved in 2020 as a 5 day topical treatment for actinic keratosis, a precancerous skin lesion characterized by the hyperproliferation of atypical keratinocytes. Tirbanibulin exerts its effects through dual mechanisms: microtubule inhibition, which disrupts cell division, and Src kinase inhibition, which interferes with cancer-associated signaling pathways. Although its primary use is in AK, these mechanisms suggested potential therapeutic applications in a broader range of epithelial cancers. In this literature review, we explored tirbanibulin's application in not only actinic keratosis, but also in squamous cell carcinoma and basal cell carcinoma. We addressed the relevant findings obtained in recent papers to evaluate tirbanibulin's safety, efficacy, side effects, real-life clinical experiences, and its potential in anti-aging and skin lightening therapies on patients. In summary, we highlighted the preclinical and clinical evidence on the use of tirbanibulin as an effective and safe treatment option beyond AK. Graphical Abstract.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, The University of Texas McGovern Medical School, 6431 Fannin St, Houston, TX, 77070, USA.
- Department of Dermatology, The University of Texas McGovern Medical School, 6431 Fannin St, Houston, TX, 77070, USA. Stephen.K.Tyring@uth.tmc.edu.
Zitieren
APA
Shen, A., Simonette, R. A., Rady, P. L., & Tyring, S. K. (2025). Clinical and experimental aspects of tirbanibulin treatments. Archives of Dermatological Research. https://doi.org/10.1007/s00403-025-04119-9
Vancouver
Shen A, Simonette RA, Rady PL, Tyring SK. Clinical and experimental aspects of tirbanibulin treatments. Archives of Dermatological Research. 2025. doi:10.1007/s00403-025-04119-9
BibTeX
@article{Shen2025,
author = {Shen, Annabel and Simonette, Rebecca A and Rady, Peter L and Tyring, Stephen K},
title = {Clinical and experimental aspects of tirbanibulin treatments},
journal = {Archives of Dermatological Research},
year = {2025},
doi = {10.1007/s00403-025-04119-9}
}
EUVIMED